Dystr is an AI-driven engineering design platform. It is essentially aiming to displace Matlab by leverging AI to make computation and workflow design more intuituve - an area I personally relate to, having suffered through years of Matlab in Chem Eng school.

Turion Space builds and operates DROID Satellites. I invested in Turion based on the technical acumen of the team and the hypothesis that space-related industry will vastly increase in the medium-to-long term.

Moneypool is Venmo for LatAm. Nuff said. This really would’ve come in handy back when I lived in Chile (2015) - the banking system in LatAm leaves much to be desired…

Buildstream helps recruitment agencies source the best matched candidates for roles. Their reply rates to outreach messages are 10x better than industry norms.

Rhipe was a software distributor in Australia, primarily distributing Microsoft and VMware software. It was a public company on the ASX, which I estimated was undervalued based on the growth of the vendors that they disributed, and the strength of their management and sales teams (who I had direct experience with). I exited with a 5X return.

Endpoint Health delivers therapies tailored to a patient’s unique biology and disease. Endpoint’s approach has shown early promise and they have partnered with incumbents to de-risk GTM. That said, this is my highest-risk investment due to the binary nature of healthcare startups.

Frame helps any fertility-related healthcare provider give their patients up-to-date and on-demand assistance. Think of it like giving anyone the “One Medical” app experience, but more hands-on and focused on fertility.